Authors:
PRONZATO P
BOTTO F
GHIO E
PENSA F
TOGNONI A
VAIRA F
VIGANI A
NERI E
Citation: P. Pronzato et al., A PHASE-II TRIAL OF CARBOPLATIN, METHOTREXATE AND FLUOROURACIL IN FLUOROURACIL-PRETREATED COLORECTAL-CANCER, Journal of chemotherapy, 10(3), 1998, pp. 254-257
Citation: O. Iribarne et F. Botto, ORIENTATION OF THE EXTANT STOUT RAZOR CLAM TAGELUS-PLEBEIUS IN RELATION TO CURRENT DIRECTION - ITS PALEOECOLOGICAL IMPLICATION, Journal of shellfish research, 17(1), 1998, pp. 165-168
Authors:
PRONZATO P
LIONETTO R
BOTTO F
PENSA F
TOGNONI A
Citation: P. Pronzato et al., HIGH-DOSE INTENSITY CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, VINCRISTINE ANDPREDNISONE BY SHORTENED INTERVALS AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY, British Journal of Cancer, 78(6), 1998, pp. 777-780
Authors:
PRONZATO P
VIGANI A
PENSA F
BOTTO F
GHIO E
NERI E
TOGNONI A
VAIRA F
Citation: P. Pronzato et al., A NEW SCHEDULE FOR ETOPOSIDE, EPIDOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED GASTRIC-CANCER - A FEASIBILITY STUDY, Anticancer research, 17(5B), 1997, pp. 3873-3876
Citation: O. Iribarne et al., BETWEEN-HABITAT DIFFERENCES IN BURROW CHARACTERISTICS AND TROPHIC MODES IN THE SOUTHWESTERN ATLANTIC BURROWING CRAB CHASMAGNATHUS-GRANULATA, Marine ecology. Progress series, 155, 1997, pp. 137-145
Authors:
SEREE EM
BOTTO F
PISANO P
LECHEVALIER E
DESOBRY A
BARRA Y
Citation: Em. Seree et al., EVIDENCE FOR THE EXISTENCE OF 2 HUMAN CYP2E1 CDNAS USING DIFFERENT POLYADENYLATION SIGNALS, Biochemical and biophysical research communications, 209(2), 1995, pp. 717-722
Authors:
BOTTO F
SEREE E
ELKHYARI S
CAU P
HENRIC A
DEMEO M
BERGERON P
BARRA Y
Citation: F. Botto et al., HYPOMETHYLATION AND HYPOEXPRESSION OF HUMAN CYP2E1 GENE IN LUNG-TUMORS, Biochemical and biophysical research communications, 205(2), 1994, pp. 1086-1092
Authors:
ELKHYARI S
BOTTO F
CARLES G
BRAGUER D
BRIAND C
BERTHOIS Y
MARTIN PM
RIVA C
BARRA Y
Citation: S. Elkhyari et al., EXPRESSION OF NUCLEAR ONCOGENES AND MARKERS OF DIFFERENTIATION IN HUMAN MULTIDRUG-RESISTANT HBL100 CELL-LINE, The Cancer journal, 6(5), 1993, pp. 285-290